Switch to: References

Add citations

You must login to add citations.
  1. Human participants challenges in youth tobacco cessation research: Researchers' perspectives.Kathleen R. Diviak, Susan J. Curry, Sherry L. Emery & Robin J. Mermelstein - 2004 - Ethics and Behavior 14 (4):321 – 334.
    Recruiting adolescents into smoking cessation studies is challenging, particularly given institutional review board (IRB) requirements for research conducted with adolescents. This article provides a brief review of the federal regulations that apply to research conducted with adolescents, and describes researchers' experiences of seeking IRB approval for youth cessation research. Twenty-one researchers provided information. The most frequently reported difficulty involved obtaining parental consent. Solutions to commonly reported problems with obtaining IRB approval are also identified. Waivers of parental consent can facilitate recruitment (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • Sexual Health Research Among Youth Representing Minority Populations: To Waive or Not to Waive Parental Consent.Bridgette M. Brawner & Madeline Y. Sutton - 2018 - Ethics and Behavior 28 (7):544-559.
    Human immunodeficiency virus and other sexually transmitted infections significantly burden youth 13–24 years of age in the United States. Directly engaging youth in sexual health research is a public health priority and urgently needed to develop targeted, youth-friendly, and culturally relevant HIV/sti prevention interventions. Controversies arise, however, regarding informed assent and consent, parental permission or consent, and the definition of “child”/“minor” as it relates to medical, legal, and ethical issues. In this article, we describe challenges in the human subjects review (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • The Ethics of Clinical Trials: A Child's View.Jennifer Rosato - 2000 - Journal of Law, Medicine and Ethics 28 (4):362-378.
    Until a few years ago, the prevailing view was that children should not be participants in clinical research trials because children were incapable of consenting to such nontherapeutic interventions and are particularly vulnerable to abuse. That view has undergone a significant shift in the last few years, particularly in the context of trials to test the safety and effectiveness of drugs. A number of events facilitated this change, including the widespread off-label distribution of drugs to children and developments in the (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations